Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed, 1 Injured in Crash on Highway 101 Near Asti Road


Vehicle Overturns in Fatal Cloverdale Accident

Fatal Accident 3

Cloverdale, CA (February 27, 2020) – One man was killed and another was injured in a crash in Cloverdale. The fatal accident occurred on the morning of February 27 on Highway 101.

A Toyota Corolla and a Toyota pickup truck collided on northbound Highway 101, near Asti Road. The Toyota crashed into the center divider and overturned in a vineyard.

The driver, Jose Torres, 25, of Santa Rosa, managed to get out of the Toyota, but another person was trapped inside. One person died from their injuries. The other was airlifted to a local hospital. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Cloverdale

#95425


February 25, 2020

Pedestrian Killed in Crash on 5 Freeway Near 710 Freeway

Victim Hit by Car in Fatal Los Angeles Accident ...


May 1, 2020

Crash at 880 Freeway and High Street Causes Minor Injuries

Semi Truck, Van Collide in Oakland Accident...


April 14, 2020

Woman Killed in Pedestrian Crash at Road 26 and Avenue 17 1/2

Victim Was Pushing Shopping Cart, Hit by Teen in Fatal Madera Accident ...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.